Ibrexafungerp 150 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 150 mg
Reference Brands: Brexafemme (USA)
Category: Anti-fungal
Ibrexafungerp is a novel oral antifungal medication that works by inhibiting (1,3)-β-D-glucan synthase, an enzyme vital for fungal cell wall synthesis. Marketed as Brexafemme in the USA, it offers the first new oral antifungal class in over 20 years. It is primarily used to treat and prevent vulvovaginal candidiasis (yeast infections) caused by Candida species.
Ibrexafungerp — third party manufacturing & bulk supply
Ibrexafungerp 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ibrexafungerp listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ibrexafungerp →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ibrexafungerp is used to treat vulvovaginal candidiasis (VVC), a vaginal yeast infection, in adult and post‑menarchal adolescent females. It is also used to reduce the chance of recurrent vulvovaginal candidiasis (RVVC).
Ibrexafungerp is a triterpenoid antifungal compound that works by inhibiting β‑1,3‑D‑glucan synthase, an enzyme essential for fungal cell‑wall synthesis. This weakens the fungal cell wall and leads to fungal death.
The trade name of Ibrexafungerp is Brexafemme.
Ibrexafungerp (Brexafemme) is manufactured by SCYNEXIS, Inc.
The generic name is ibrexafungerp.
The brand name is Brexafemme.
Ibrexafungerp is manufactured by SCYNEXIS, Inc., and is available in certain markets as an oral tablet under the brand Brexafemme.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
